ID: ALA2335380

Max Phase: Preclinical

Molecular Formula: C11H16N4O

Molecular Weight: 220.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)c1cc2c(cc1N)n(C)c(=O)n2C

Standard InChI:  InChI=1S/C11H16N4O/c1-13(2)8-6-10-9(5-7(8)12)14(3)11(16)15(10)4/h5-6H,12H2,1-4H3

Standard InChI Key:  OUKLITHWMNPWMM-UHFFFAOYSA-N

Associated Targets(Human)

S-100 protein beta chain 30 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 220.28Molecular Weight (Monoisotopic): 220.1324AlogP: 0.53#Rotatable Bonds: 1
Polar Surface Area: 56.19Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.47CX LogP: 0.51CX LogD: 0.51
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.71Np Likeness Score: -0.85

References

1. Yoshimura C, Miyafusa T, Tsumoto K..  (2013)  Identification of small-molecule inhibitors of the human S100B-p53 interaction and evaluation of their activity in human melanoma cells.,  21  (5): [PMID:23375094] [10.1016/j.bmc.2012.12.042]

Source